Desenvolvimento de Novas Metodologias para o Mapeamento Multimodal da Mácula
Bernardes R.
PhD Tesis, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 2008.
2008
Desenvolvimento de Novas Metodologias para o Mapeamento Multimodal da Mácula
Desenvolvimento de Novas Metodologias para o Mapeamento Multimodal da Mácula
Bernardes R.
PhD Tesis, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 2008.
2008
Multimodal mapping of the macula.
Multimodal mapping of the macula.
Bernardes R., Lobo C., Cunha-Vaz J.
Ophthalmol. Intern., Summer 2008; 3 (2): 58-61.
2008
Characterization and relevance of different diabetic retinopathy phenotypes.
Characterization and relevance of different diabetic retinopathy phenotypes.
Cunha-Vaz, J.G
In: Diabetic Retinopathy. Lang GE. Ed. Basel, Karger. Dev. Ophthalmol. 2007, 39, 13-30.
2007
Intravitreal Steroid Injections In Combination With Laser Treatments For Severe Diabetic Retinopathy.
Intravitreal Steroid Injections In Combination With Laser Treatments For Severe Diabetic Retinopathy.
Cunha-Vaz, J.G
Int. Diabetes Monitor. 2007,19(3):36-37.
2007
A European network of certified clinical trials centers of ophthalmology: EVI.CT.SE.
A European network of certified clinical trials centers of ophthalmology: EVI.CT.SE.
Cunha-Vaz, J.
Expert. Rev. Ophthalmol. 2007; 2 (1):61-63.
2007
Ruboxistaurin in patients with diabetic macular edema.
Ruboxistaurin in patients with diabetic macular edema.
Cunha-Vaz, J.G.
International Diabetes Monitor. 2007, Vol. 19, Number 6: 25-26.
2007
Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and indentification of risk factors.
Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and indentification of risk factors.
ESCRS Endophthalmitis Group
J. Cataract. Surg. 2007, 33:978-988.
2007
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.
Macugen AMD Study Group
Ophthalmology. 2007; 114:1702-1712.
2007
Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study.
Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study.
Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I; The European Glaucoma Prevention Study (EGPS) Group
Am J Ophthalmol. 2007 Aug; 144(2):266-275.
2007
Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.
Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.
Nardi, M., Lobo, C., Bereczki, A., Cano, J., Zagato, E., Potts, S., Sullins, G., Notivol, R., for the International C-04-65 Study Group
Clinical Ophthalmology 2007:1(4) 527-533.
2007